Sherif Idriss | CEO | Elastin Bioscience
After an initial training as a pharmacist, 12 years ago, I was trained as a pharmacologist in Oxford then obtained a PhD in Neuroscience from University of Lubeck in Germany. With a highly diverse training in biomedical sciences, I worked as a postdoctoral fellow in University of Bern, to contribute to the drug discovery efforts for multiple sclerosis. After a few years in the biopharma consulting world, I joined Longaevus Technologies as an Entrepreneur in Residence. My project was a success and we established Elastin Biosciences.
Elastin Biosciences is a spin-off from Longaevus Technologies. We have pioneered a first-in-class Elastin-restoration platform technology, using small molecules. Using a single therapeutic and a combination-therapy approach, we have shown for the first time increased elastin expression in vivo combined with improved aortic structural integrity and function. Our technology has huge implications for elastin-deficiency diseases, as well as a huge potential for a wide range of applications.
Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Register here
|
© Copyright 2023 by Hyphen Projects